Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Minerva Neurosciences, Inc. Director's Dealing 2018

Jun 11, 2018

35086_dirs_2018-06-11_08eca13e-edc7-4b0a-ac4c-96d0d0564e19.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2018-06-07

Reporting Person: HASLER HANS PETER (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-06-07 Stock Option (Right to Buy) $8.25 A 20000 Acquired 2028-06-06 Common Stock (20000) Direct

Footnotes

F1: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 7, 2018 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date.